Limited Distribution Deals Announced
Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the press releases rarely
August 11, 2022
Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the press releases rarely
The FDA just approved another biosimilar! That’s always big news that often starts a panic in the healthcare industry…. said no one ever. However, this new
CVS recently released its a Drug Trend Report for 2021. Caremark found that 35.9% of its clients saw negative specialty trend in 2021. In addition, 65.3% saw
Walgreens continues to morph into a diverse health services company. The headline of the article below isn’t the real news. Rather, the article below lists
Curiouser and curiouser…….Over the past three years the three largest PBMs each formed a GPO to, in their words, “capitalize on scale to get better
We’ve been watching the slow but steady growth of value based contracting (VBCs) for some years now. Conceptually VBCs make a lot of sense. Payors
Fins to the left of me…… fins to the right….. and I’m the only PBM in town….(with apologies to Jimmy Buffet) What we are really
Last week we sent two reports highlighting the increasing pressure on PBMs in response to onerous business practices. The first described action being taken in
Earlier this week we issued a report on PBM business practices coming under increased scrutiny at the federal level. Well, the bullseye is not limited
PBMs continue to be under the microscope. The scrutiny comes on the heels of the FTC announcing that it was reversing its decision to shelf taking
